On Aug 31, 2021 Versanis Bio closed a Series A round and raised $70,000,000 from Aditum Bio, Atlas Venture, Medicxi Ventures, featuring lead investors Atlas Venture, Medicxi Ventures.

About the company: Versanis Bio is located at United States, North America.
“Discovering and developing first-in-class medicines that address medical conditions prevalent in old age”

Company website: http://www.versanisbio.com